SCHEMBL7952009

SCHEMBL7952009

CC(C)(C)c1cc(C=C(C#N)S(=O)(=O)c2cccc(C(F)(F)F)c2)cc(Br)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.51
CISD1 Q9NZ45 1/20 0.51
EGFR P00533 2/20 0.43
KMT2A Q03164 6/20 0.41
ALDH1A1 P00352 6/20 0.41
MEN1 O00255 5/20 0.41
HPGD P15428 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
HSD17B10 Q99714 4/20 0.41
PKM P14618 4/20 0.41
KDM4E B2RXH2 4/20 0.41
ALOX15 P16050 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
POLB P06746 1/20 0.41
ALPG P10696 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPT P10636 5/20 0.39
LMNA P02545 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7952006 1.00 IGF1R (0.51) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL7952007 1.00 IGF1R (0.51) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL7961600 0.93 HPGD (0.46) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL7961597 0.93 HPGD (0.46) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL7961602 0.93 HPGD (0.46) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL7952731 0.89 IGF1R (0.54) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL7952727 0.89 IGF1R (0.54) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL7952729 0.89 IGF1R (0.54) IGF1RCISD1EGFRKMT2AALDH1A1
SCHEMBL8323332 0.88 EGFR (0.58) EGFRKMT2AALDH1A1MEN1HPGD
SCHEMBL9231430 0.88 EGFR (0.58) EGFRKMT2AALDH1A1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed